Journal of Biological Chemistry · 2022 · 10 citations · 36 references
Life SciencesImmunologyMolecular BiologyGene ExpressionInnate ImmunityMolecular VirologyAntiviral ImmunityInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysInterferon ResponsesViral Protein ProcessingAntiviral Innate SignalingE3 Ubiquitin Ligase Substrate RecognitionInnate Immunity PathwaysLigand DegradationProteasome SystemReceptor DegradationRegulation By E3 Ubiquitin LigasesUbiquitin-proteasome Proteolysis
Influenza remains a major public health challenge, as the viral infection activates multiple biological networks linked to altered host innate immunity. Following infection, IFN-λ, a ligand crucial for the resolution of viral infections, is known to bind to its cognate receptor, IFNLR1, in lung epithelia. However, little is known regarding the molecular expression and regulation of IFNLR1. Here, we show that IFNLR1 is a labile protein in human airway epithelia that is rapidly degraded after influenza infection. Using an unbiased proximal ligation biotin screen, we first identified that the Skp-Cullin-F box E3 ligase subunit, FBXO45, binds to IFNLR1. We demonstrate that FBXO45, induced in response to influenza infection, mediates IFNLR1 protein polyubiquitination and degradation through the ubiquitin-proteasome system by docking with its intracellular receptor domain. Furthermore, we found ectopically expressed FBXO45 and its silencing in cells differentially regulated both IFNLR1 protein stability and interferon-stimulated gene expression. Mutagenesis studies also indicated that expression of a K319R/K320R IFNLR1 variant in cells exhibited reduced polyubiquitination, yet greater stability and proteolytic resistance to FBXO45 and influenza-mediated receptor degradation. These results indicate that the IFN-λ-IFNLR1 receptor axis is tightly regulated by the Skp-Cullin-F box ubiquitin machinery, a pathway that may be exploited by influenza infection as a means to limit antiviral responses.
36
Dorota Skowyra, Karen Craig, Mike Tyers et al. · Cell · 1997 · 1.2K citations · Full text
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
Jack Major, Stefania Crotta, Miriam Llorian et al. · Science · 2020 · 510 citations · Full text
Ioanna E. Galani, Vasiliki Triantafyllia, Evridiki-Evangelia Eleminiadou et al. · Immunity · 2017 · 487 citations · Full text
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi, Sreya Ghosh, Benedetta Sposito et al. · Science · 2020 · 416 citations · Full text